Nägler et al., 2004 - Google Patents
Up‐regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasiaNägler et al., 2004
- Document ID
- 9804116614932062555
- Author
- Nägler D
- Krüger S
- Kellner A
- Ziomek E
- Menard R
- Buhtz P
- Krams M
- Roessner A
- Kellner U
- Publication year
- Publication venue
- The Prostate
External Links
Snippet
BACKGROUND Evidence is accumulating that several proteases are involved in prostate cancer progression. A locus which is often amplified in prostate cancer is the chromosomal region 20q13. Interestingly, one of the genes encoding the cysteine protease cathepsin X …
- 108030001421 EC 3.4.18.1 0 title abstract description 77
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nägler et al. | Up‐regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia | |
| Davidson et al. | EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma | |
| Chenard et al. | High levels of stromelysin‐3 correlate with poor prognosis in patients with breast carcinoma | |
| Guan et al. | Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications | |
| Gratio et al. | Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells | |
| Kuefer et al. | The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer | |
| Keppler et al. | Cathepsin B: multiple enzyme forms from a single gene and their relation to cancer | |
| Tanimoto et al. | Increased expression of protease M in ovarian tumors | |
| Bowden et al. | Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer | |
| JP4942052B2 (en) | Diagnosis of ovarian endometriosis | |
| JP2008156353A (en) | Pharmaceutical composition for inhibiting metastasis of cancer of epithelial cell origin | |
| Ishiwata et al. | State of heat shock factor 1 expression as a putative diagnostic marker for oral squamous cell carcinoma | |
| Robert et al. | Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression | |
| US9182415B2 (en) | Use of IMP3 as a prognostic marker for cancer | |
| US20060105343A1 (en) | Methods for diagnosis and prognosis of cancer | |
| Kim et al. | Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer | |
| US6864093B1 (en) | Method of identifying and treating invasive carcinomas | |
| US20040137455A1 (en) | Diagnosis of cancer or benign tumor using the aberrant expression product of the klk4 gene | |
| US8980638B2 (en) | Use of IMP3 as a prognostic marker for cancer | |
| US5723302A (en) | Detection of prostate-specific antigen in breast tumors | |
| JP6519927B2 (en) | Use of RHOA in cancer diagnosis, inhibitor screening | |
| Delbaldo et al. | Plasmin-catalyzed proteolysis in colorectal neoplasia | |
| Munck-Wikland et al. | Stromelysin-3 mRNA expression in dysplasias and invasive epithelial cancer of the larynx. | |
| Bhatavdekar et al. | Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience | |
| Liu et al. | Expression of cytoplasmic p16 and anion exchanger 1 is associated with the invasion and absence of lymph metastasis in gastric carcinoma |